Evidence map›Paper›PMID 40331678›Full record

ArticleChemical research in toxicology2025

Identification and Structural Elucidation of a Novel Pyrrolidinophenone-Based Designer Drug on the Illicit Market: α-BPVP.

Sara Casati, Roberta F Bergamaschi, Riccardo Primavera, Alessandro Ravelli, Ivana Lavota, Alessio Battistini, Gabriella Roda, Chiara Ciccarelli, Claudio Guidotti, Paola Rota

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sara CasatiDipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, 20133 Milan, Italy.ORCID 0000-0002-5049-7321
Roberta F BergamaschiDipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, 20133 Milan, Italy.
Riccardo PrimaveraDipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, 20133 Milan, Italy.
Alessandro RavelliDipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, 20133 Milan, Italy.
Ivana LavotaInstitute for Molecular and Translational Cardiology (IMTC), San Donato Milanese, 20097 Milan, Italy.
Alessio BattistiniDipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, 20133 Milan, Italy.
Gabriella RodaDipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, 20133 Milan, Italy.
Chiara CiccarelliGabinetto Regionale di Polizia Scientifica per la Lombardia, Polizia di Stato, Via Fatebenefratelli 11, 20121 Milan, Italy.
Claudio GuidottiGabinetto Regionale di Polizia Scientifica per la Lombardia, Polizia di Stato, Via Fatebenefratelli 11, 20121 Milan, Italy.
Paola RotaDipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, 20133 Milan, Italy.ORCID 0000-0001-5795-4989

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of a new psychoactive substances (NPS) with a cathinone structure and a biphenyl substituent, found in seized powder from the black market, is here reported. By combining analytical techniques, including 1D and 2D NMR and HRMS, the compound was identified as 1-([1,1'-biphenyl]-4-yl)-2-(pyrrolidin-1-yl)pentan-1-one (α-BPVP), an α-pyrrolidinopentiophenone (α-PVP) analogue featuring a biphenyl group instead of the phenyl ring. This previously unreported molecule raises urgent legal and public health concerns, which warrants further toxicological investigation.

Indexed as

Designer DrugsIllicit DrugsPentanonesPyrrolidinesMagnetic Resonance SpectroscopyMolecular StructureDesigner DrugsIllicit DrugsPentanonesPyrrolidines

Identifiers

PMID40331678
PMCPMC12093358

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.